Nalaganje...
Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?
Following initial success in melanoma and lung tumours, immune checkpoint inhibitors (ICIs) are now well recognized as a major immunotherapy treatment modality for multiple types of solid cancers. In colorectal cancer (CRC), the small subset that is mismatch-repair-deficient and microsatellite-insta...
Shranjeno v:
| izdano v: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034232/ https://ncbi.nlm.nih.gov/pubmed/32104582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goz061 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|